Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Genetic Re-programming of Stem Cells to Fight Cancer

  • Post author:
  • Post published:December 18, 2025
  • Post category:

Science has made great progress in the treatment of certain cancers with targeted and combination therapies, yet prolonged remissions or cures are rare because most cancer therapies only inhibit cell…

Continue ReadingGenetic Re-programming of Stem Cells to Fight Cancer

Progenitor Cells Secreting GDNF for the Treatment of ALS

  • Post author:
  • Post published:December 18, 2025
  • Post category:

This project aims to use a powerful combined neural progenitor cell and growth factor approach to treat patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig’s Disease). ALS is a…

Continue ReadingProgenitor Cells Secreting GDNF for the Treatment of ALS

Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia

  • Post author:
  • Post published:December 18, 2025
  • Post category:

Critical limb ischemia (CLI) represents a significant unmet medical need without any approved medical therapies for patients who fail surgical or angioplasty procedures to restore blood flow to the lower…

Continue ReadingPhase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia

MSC engineered to produce BDNF for the treatment of Huntington’s disease

  • Post author:
  • Post published:December 18, 2025
  • Post category:

One in every ten thousand people in the USA has Huntington's disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingMSC engineered to produce BDNF for the treatment of Huntington’s disease

Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells

  • Post author:
  • Post published:December 18, 2025
  • Post category:

While current treatment strategies for high-grade glioma can yield short term benefits, their inability to eradicate the highly tumorigenic cancer stem cell population results in disease recurrence in the vast…

Continue ReadingTargeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells

Direct Cardiac Reprogramming for Heart Regeneration

  • Post author:
  • Post published:December 18, 2025
  • Post category:

Heart disease is a leading cause of mortality. The underlying pathology is typically loss of heart muscle cells that leads to heart failure. Because heart muscle has little or no…

Continue ReadingDirect Cardiac Reprogramming for Heart Regeneration

Human ES cell based therapy of heart failure without allogenic immune rejection

  • Post author:
  • Post published:December 18, 2025
  • Post category:

Heart failure is a major and ever-growing health problem affecting an estimated 5.8 million Americans with about half a million new cases every year. There are limited therapeutic options for…

Continue ReadingHuman ES cell based therapy of heart failure without allogenic immune rejection

Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID

  • Post author:
  • Post published:December 18, 2025
  • Post category:

Artemis is a chemical in all cells in the body that is essential for the normal development of the immune system and repairing damaged DNA. Artemis deficiency (AD) causes Severe…

Continue ReadingGene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID

Stem Cell Therapy for Duchenne Muscular Dystrophy

  • Post author:
  • Post published:December 18, 2025
  • Post category:

Duchenne muscular dystrophy (DMD) is the most common and serious form of muscular dystrophy. One out of every 3500 boys is born with the disorder, and it is invariably fatal.…

Continue ReadingStem Cell Therapy for Duchenne Muscular Dystrophy

Development of RNA-based approaches to stem cell gene therapy for HIV

  • Post author:
  • Post published:December 18, 2025
  • Post category:

Despite significant advances in treatment and prevention programs, HIV infection with progression to Acquired Immunodeficiency Syndrome (AIDS) is still prevalent in California. The CDC Estimates >56,000 new cases of HIV…

Continue ReadingDevelopment of RNA-based approaches to stem cell gene therapy for HIV
  • Go to the previous page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 26
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us